ALPHA3 Trial

South San Francisco, California | April 13, 2026 Allogene Therapeutics has announced encouraging interim results from its pivotal Phase...

South San Francisco, California | April 10, 2026 Allogene Therapeutics has announced that it will present the interim futility...